Delivery Order SPE2DB22D2206-SPE2DB24FJS74

Award Date 8/9/24
Potential Completion Date 8/30/24
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of CABOMETYX 40 MG TABLET 30S, a specialty medication, with a ceiling value of $27,734.36 and a performance period through September 18, 2024. This contract is a delivery order issued under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABOMETYX 60 MG TABLET 30S, a pharmaceutical product, and has a ceiling value of $15,301.05. The contract has an ultimate completion date of April 22, 2025. There is no set-aside designation for this award. AmerisourceBergen holds a larger $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CABOMETYX 40 MG TABLET 30S. The $61,386.20 firm fixed-price delivery order contract has an ultimate completion date of March 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of CABOMETYX 60 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price of $27,816.56 and a period of performance ending on October 7, 2024. The contract is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this order, which is part of a larger Indefinite...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CABOMETYX 60 MG TABLET 30S. The contract has a ceiling value of $15,301.05 and a period of performance through July 22, 2025. This award is not set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CABOMETYX 60 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $15,301.05 and a completion date of July 30, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,301.05, is for the supply of CABOMETYX 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 21, 2025 and is a Firm Fixed Price contract. There is no set-aside designation indicated for this award. AmerisourceBergen holds a significant Indefinite...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $15,346.55 and a period of performance through July 28, 2025. The contract is a firm fixed-price delivery order and is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABOMETYX 40 MG TABLET 30S, a medication. The contract has a ceiling value of $15,346.55 and a period of performance through July 24, 2025. The contract is a Firm Fixed Price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CABOMETYX 40 MG TABLET 30S. The contract has a ceiling value of $27,734.36 and a period of performance through September 20, 2024. It is a firm fixed-price contract. Amerisourcebergen, through its Corporate Office division, is the prime contractor and has been awarded numerous federal contracts by the DLA and other agencies to...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJS74
    Delivery Order

This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CABOMETYX 60 MG TABLET 30S. The contract has a ceiling value of $27,816.56 and an ultimate completion date of August 30, 2024. This appears to be a Delivery Order contract with a Firm Fixed Price pricing type. The contract is not set-aside for any special designations. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, for the supply of a wide range of pharmaceutical and medical products to support various federal healthcare programs and facilities, including military treatment centers and veterans' hospitals.

Generated 11/8/24, 9:08 AM